These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17931799)

  • 1. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
    Pramana J; Van den Brekel MW; van Velthuysen ML; Wessels LF; Nuyten DS; Hofland I; Atsma D; Pimentel N; Hoebers FJ; Rasch CR; Begg AC
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1544-52. PubMed ID: 17931799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
    Villar A; Martinez JC; de Serdio JL
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H; Phan T; Mackinnon J; Matthews TW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.
    Rades D; Kronemann S; Meyners T; Bohlen G; Tribius S; Kazic N; Schroeder U; Hakim SG; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1037-44. PubMed ID: 20638185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation.
    Giri U; Ashorn CL; Ramdas L; Stivers DN; Coombes K; El-Naggar AK; Ang KK; Story MD
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):670-7. PubMed ID: 16289374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response.
    Starmans MH; Zips D; Wouters BG; Baumann M; Lambin P
    Radiother Oncol; 2009 Sep; 92(3):417-22. PubMed ID: 19615772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
    Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
    Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of neck treatment in patients with head and neck squamous cell carcinoma.
    Buck G; Huguenin P; Stoeckli SJ
    Head Neck; 2008 Jan; 30(1):50-7. PubMed ID: 17636542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RADPLAT: an alternative to surgery?
    Alkureishi LW; de Bree R; Ross GL
    Oncologist; 2006 May; 11(5):469-80. PubMed ID: 16720847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
    Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
    van den Broek GB; Wreesmann VB; van den Brekel MW; Rasch CR; Balm AJ; Rao PH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4386-91. PubMed ID: 17671120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer.
    Sarkar SK; Patra NB; Goswami J; Basu S
    J Laryngol Otol; 2008 Feb; 122(2):188-92. PubMed ID: 17445333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.